1203 SAFETY PROFILE OF DACLATASVIR IN COMBINATION WITH PEGINTERFERON alfa AND RIBAVIRIN IN 1100 PATIENTS WITH CHRONIC HCV INFECTION TREATED IN PHASE 2 STUDIES
Jacobson, I., Dimitrova, D., Hughes, E.A., Yin, P.D., Mendez, P., Yogendran, L., Schnittman, S.Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)61204-0
Date:
April, 2013
File:
PDF, 53 KB
english, 2013